NB:NASDAQNioCorp Developments Ltd. Analysis
Data as of 2026-06-21 - not real-time
$5.31
Latest Price
8/10Risk
Risk Level: High
Executive Summary
NioCorp is trading at $5.31, which sits below its 20‑day SMA of $5.50, 50‑day SMA of $5.65, and 200‑day SMA of $6.03, indicating a clear bearish technical backdrop. The RSI hovers around 47 and the MACD line is under the signal line, reinforcing short‑term downside momentum, while a beta of 2.41 and a 30‑day volatility of over 80% flag extreme price swings.
On the fundamentals side, the company holds $419 million in cash against a negligible $0.38 million debt load, giving it a very low debt‑to‑equity ratio of 0.09. However, it reports zero revenue, negative EBITDA of $33.7 million, and a trailing EPS of –$0.58, placing it in a loss‑making, pre‑production phase. Its price‑to‑book ratio of 0.71 suggests the market is discounting the net asset value, while analyst consensus (5 analysts) rates the stock as a strong buy with a median target of $12, implying upside potential of roughly 120% from current levels.
Given the high volatility, lack of operating cash flow, and early‑stage development risk, investors should treat NB as a high‑risk, high‑reward play, focusing on the company’s cash runway and long‑term commodity demand rather than short‑term price trends.
On the fundamentals side, the company holds $419 million in cash against a negligible $0.38 million debt load, giving it a very low debt‑to‑equity ratio of 0.09. However, it reports zero revenue, negative EBITDA of $33.7 million, and a trailing EPS of –$0.58, placing it in a loss‑making, pre‑production phase. Its price‑to‑book ratio of 0.71 suggests the market is discounting the net asset value, while analyst consensus (5 analysts) rates the stock as a strong buy with a median target of $12, implying upside potential of roughly 120% from current levels.
Given the high volatility, lack of operating cash flow, and early‑stage development risk, investors should treat NB as a high‑risk, high‑reward play, focusing on the company’s cash runway and long‑term commodity demand rather than short‑term price trends.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below all major moving averages
- Bearish MACD and neutral RSI
- Extreme 30‑day volatility and high beta
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong cash position with minimal debt
- Analyst consensus strong‑buy and $12 median target
- Potential catalyst from upcoming corporate events and project milestones
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic exposure to niobium, scandium, and titanium markets
- Undervalued book value relative to assets
- Long‑term upside if Elk Creek project reaches production
Key Metrics & Analysis
Financial Health
P/E Ratio-20.6
ROE-24.54%
ROA-8.70%
Debt/Equity0.09
P/B Ratio0.7
Op. Cash Flow$-16672000
Free Cash Flow$-28075624
Technical Analysis
TrendBearish
RSI47.1
Support$4.76
Resistance$6.38
MA 20$5.50
MA 50$5.65
MA 200$6.03
MACDBearish
VolumeStable
Fear & Greed Index91.46
Valuation
Target Price$11.70
Upside/Downside120.34%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta2.41
Volatility82.59%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
NTDOY
Nintendo Co., Ltd.
STOCKAPLE
Apple Hospitality REIT, Inc.
STOCKZIM
ZIM Integrated Shipping Services Ltd.
STOCKYJ
Yunji Inc. - American Depository Shares
STOCKXENE
Xenon Pharmaceuticals Inc.
STOCKWTFCN
Wintrust Financial Corporation - Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 7.875% Fixed-Rate Reset Non-Cumulative Perpetual Prefer
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.